A detailed history of Artal Group S.A. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Artal Group S.A. holds 720,720 shares of FHTX stock, worth $5.82 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
720,720
Previous 720,720 -0.0%
Holding current value
$5.82 Million
Previous $4.84 Million 14.31%
% of portfolio
0.26%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$2.94 - $6.76 $2.94 Million - $6.76 Million
-1,000,000 Reduced 58.12%
720,720 $4.65 Million
Q4 2020

Feb 11, 2021

BUY
$15.12 - $25.88 $26 Million - $44.5 Million
1,720,720 New
1,720,720 $34.9 Million

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.